Methyl (2E)-2-[(2-chloropyridin-3-yl)sulfonyl]-3-(dimethylamino)prop-2-enoate

Catalog No. :
ACEKZQ985
CAS No. :
931359-99-8
Molecular Formula :
C11H13ClN2O4S
Molecular Weight :
304.76

IUPAC Name:methyl (E)-2-((2-chloropyridin-3-yl)sulfonyl)-3-(dimethylamino)acrylate

Methyl (2E)-2-[(2-chloropyridin-3-yl)sulfonyl]-3-(dimethylamino)prop-2-enoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$339.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl (2E)-2-[(2-chloropyridin-3-yl)sulfonyl]-3-(dimethylamino)prop-2-enoate
IUPAC Namemethyl (E)-2-((2-chloropyridin-3-yl)sulfonyl)-3-(dimethylamino)acrylate
MDL No.MFCD09981361
Molecular FormulaC11H13ClN2O4S
Molecular Weight304.76
SMILESO=C(OC)/C(S(=O)(C1=CC=CN=C1Cl)=O)=C\N(C)C
InChI KeyQCXDVBOQRWVMGB-VQHVLOKHSA-N
Synonym2-(2-Chloro-pyridine-3-sulfonyl)-3-dimethylamino-acrylic acid methyl ester;2-Propenoic acid, 2-[(2-chloro-3-pyridinyl)sulfonyl]-3-(dimethylamino)-, methyl ester
CAS No.931359-99-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACEKZQ985 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTGPV071 route compound structure diagram
    ACTGPV071999-59-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEKZQ985 route product structure diagram
    ACEKZQ985931359-99-8
Inquiry

2. ACEKZQ985 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEKZQ985 route product structure diagram
    ACEKZQ985931359-99-8
Inquiry

Comments (0)